At a glance
- Originator Merck & Co
- Class Antivirals
- Mechanism of Action DNA-directed RNA polymerase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Influenza virus infections in USA (Unknown route)
- 01 Feb 1995 Preclinical development for Influenza virus infections in USA (Unknown route)